- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Cipla's subsidiary InvaGen's USFDA inspection at its Central Islip facility is classified as Voluntary Action Indicated (VAI). This signals no immediate regulatory enforcement action, a positive development for operations.